Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case–control study with or without antidepressant therapy
Abstract Objective We do not have any consistent markers for major depressive disorder (MDD) though various biological factors are involved in the pathophysiology. We aimed to evaluate the serum brain-derived neurotrophic factor (BDNF) levels in MDD patients with or without antidepressant therapy co...
Main Authors: | Md. Prova Zaman Emon, Rajesh Das, Nuruna Lovely Nishuty, M. M. A. Shalahuddin Qusar, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-020-04952-3 |
Similar Items
-
BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response
by: Klaus Lieb, et al.
Published: (2018-10-01) -
Serum BDNF and suicidal ideation in drug-naïve and drug-treated MDD patients: a case–control study
by: Amira Mohamed Yousef, et al.
Published: (2021-06-01) -
Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder
by: Md. Rabiul Islam, et al.
Published: (2020-06-01) -
Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
by: Anna Mosiołek, et al.
Published: (2021-07-01) -
Brain-derived neurotrophic factor enhances the therapeutic effect of oleuropein in the lipopolysaccharide-induced models of depression
by: A-na Xu, et al.
Published: (2021-09-01)